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Abstract
Heterotrimeric G proteins are ubiquitous signaling partners of seven transmembrane-domain G-
protein-coupled receptors (GPCRs), the largest (and most important pharmacologically) receptor
family in mammals. A number of scaffolding proteins have been identified that regulate various
facets of GPCR signaling. In this review, we summarize current knowledge concerning those
scaffolding proteins that are known to directly bind heterotrimeric G proteins, and discuss the
composition of the protein complexes they assemble and their effects on signal transduction.
Emerging evidence about possible ways of regulation of activity of these scaffolding proteins is also
discussed.
Background
The concept of scaffolding (or scaffold) proteins, formu-
lated more than a decade ago (see [1] for an early review),
is now widely accepted in different areas of cellular sign-
aling. Scaffolding proteins simultaneously associate with
two or more partners, thus providing specificity of signal-
ing and enhancing the interactions between components
of a particular signaling module [2,3]. It should be men-
tioned that scaffolding proteins may not necessarily only
function as "passive" anchoring platforms for "active"
components of the signaling complex. Some scaffolding
proteins may directly affect the activity of proteins they
bind.
Heterotrimeric G proteins (recent reviews: [4,5]) are ubiq-
uitous signaling partners of seven transmembrane-
domain G-protein-coupled receptors (GPCRs), the largest
(and most important pharmacologically) receptor family
in mammals. In addition to their role in signal transduc-
tion from canonical GPCRs, heterotrimeric G proteins are
also involved in signaling downstream of a number of
"non-canonical" receptors [6] and signaling events that
do not employ transmembrane receptors at all [7]. While
the number of G protein-coupled receptors in mamma-
lian cells exceeds 1000, the number of heterotrimeric G
proteins is much smaller, even taking into account the
number of possible combinations of α, β and γ subunits.
In the recent years, it has become clear that scaffolding
proteins may provide not only signaling efficiency, but
also specificity to G protein-coupled signaling.
This review aims to address the variety of scaffolding pro-
teins that interact with heterotrimeric G proteins and the
diversity of the signaling complexes they assemble. Pro-
teins that belong to the classes of regulators (RGS) and
activators (AGS) of heterotrimeric G-protein signaling,
many of which can also act as scaffolds, have been
recently covered in other reviews, and the reader is
referred to the respective recent publications (RGS pro-
teins: [8,9]; AGS proteins: [10,11]).
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AKAPs
A-Kinase Anchoring Proteins (AKAPs) are a family of scaf-
folding proteins that target PKA and other signaling
enzymes to specified subcellular locations [12,13]. Each
AKAP contains a conserved amphipathic helix responsible
for high affinity binding to the dimer of the regulatory (R)
subunits of PKA [14,15], and a targeting domain that
directs the PKA-AKAP complex to specific subcellular
compartments [16-20]. Due to their ability to interact
with several signaling proteins, AKAPs bring PKA in a
close proximity with a variety of signaling partners [21-
25]. Several AKAPs play a role in various aspects of G pro-
tein-coupled receptor signaling [26], and at least two of
them directly interact with heterotrimeric G proteins.
AKAP-Lbc  was identified as a PKA-anchoring protein
highly expressed in the heart that also has a Rho-specific
guanine nucleotide exchange (GEF) activity ([27,28]
reviewed by [29]). It was shown to interact with Rho in
the inactive GDP-bound or nucleotide free form, but not
with activated GTP-bound Rho. AKAP-Lbc was found to
mediate activation of Rho by mutationally activated Gα12
and, to a lesser extent, by Gα13, but not several other
tested Gα [28]. Moreover, AKAP-Lbc was shown to inter-
act with Gα12 and to mediate Gα12-dependent Rho activa-
tion by lysophosphatidic acid (LPA) receptor ([28]; Fig.
1A) and by α1 adrenergic receptor, in the latter case medi-
ating cardiomyocyte hypertrophy [30]. Anchored PKA
phosphorylates AKAP-Lbc, thus allowing binding of 14-3-
3, which in turn inhibits its RhoGEF activity by interfering
with the interaction between AKAP-Lbc and RhoA
[31,32]. Inhibition of RhoGEF activity by 14-3-3 requires
AKAP-Lbc oligomerization [33]. These findings imply that
cellular cAMP levels would regulate sensitivity of Gα12-
dependent signaling via AKAP-Lbc. AKAP-Lbc may also
anchor PKCα, which might phosphorylate Rho or Rho
GDP dissociation inhibitor (RhoGDI) although its precise
role in the AKAP-Lbc complex is unknown [24].
AKAP-Lbc also assembles an activation complex for the
lipid-dependent enzyme protein kinase D (PKD) [24]. It
contributes to PKD activation in two ways: it recruits the
upstream kinase PKCη and coordinates PKA phosphor-
ylation events that release activated protein kinase D.
Thus, AKAP-Lbc synchronizes PKA and PKC activities in a
manner that leads to the activation of a third kinase, PKD
[24].
Notably, in both cases (Gα12-Rho and PKA/PKC-PKD sig-
naling) AKAP-Lbc receives signals from G protein-coupled
receptors. It is not yet clear whether the same AKAP-Lbc
complex may involve simultaneously Gα12/Rho and PKC/
PKD and process these signals in parallel, or AKAP-Lbc/
Gα12/Rho and AKAP-Lbc/PKC/PKD represent separate
and independent signaling complexes.
AKAP110, expressed mainly in testis, was found to selec-
tively interact with activated Gα13, but not Gα12 or other
Gα [34]. Unlike AKAP-Lbc, AKAP110 does not affect
GDP-GTP exchange by Rho (J. Niu and T. Voyno-Yasenet-
skaya, unpublished data). It also has no effect on GDP-
GTP exchange and GTPase activity of Gα13 [34]. Gα13
binding to AKAP110 does not affect binding of the regu-
latory subunit of PKA, but leads to a release of the catalytic
subunit (Fig. 1B). Thus, AKAP-110 appears to be a Gα13
effector that provides a cAMP-independent mechanism of
PKA activation.
Interestingly, the PKA-binding site of AKAP110 is also
able to bind ropporin [35]. Ropporin is known to bind
rhophilin, which is a Rho binding protein and presuma-
ble Rho effector [36]. Thus, although activation of PKA by
Gα13  via  AKAP110 is Rho-independent, it cannot be
excluded that AKAP110 may provide yet undefined addi-
tional link between Gα13 and Rho signaling.
AKAP120. Yet another PKA-anchoring protein, AKAP120,
has been suggested to specifically interact with Gα13 but
not several other Gα [37]. However the initial finding
using the yeast two hybrid system has not been confirmed
by other techniques, and no further studies of the Gα13-
AKAP120 interaction have been reported. AKAP120
described in Ref. [37] is actually a fragment of one of the
several alternatively spliced isoforms derived from the
same gene, which include AKAPs 350, 450 and Yotiao.
These proteins are located at centrosomes and/or Golgi
apparatus and affect microtubule dynamics (AKAP350/
450), or regulate cardiac potassium channel (Yotiao)
[38,39]. It would be important to establish whether any of
these isoforms are able to interact with Gα13.
Tetratricopeptide repeat (TPR)-containing 
scaffolding proteins
TPR1 was initially identified as a protein containing three
TPR motifs, which interacts with the GAP domain of neu-
Schematic representation of Gα12/Gα13-containing signaling  complexes assembled by A-kinase anchoring proteins  (AKAPs): AKAP-Lbc (A) and AKAP-110 (B) Figure 1
Schematic representation of Gα12/Gα13-containing signaling 
complexes assembled by A-kinase anchoring proteins 
(AKAPs): AKAP-Lbc (A) and AKAP-110 (B). See main text 
for details and references.
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rofibromin (NF1) [40]. It also interacts with and is a co-
chaperone of Hsp70 [41,42]. TPR1 was found to interact
with Gα16, as well as Gαq, Gαs, and to a much lesser extent
with Gαi (but not Gα13 or Gαt), as well as with HA-Ras
(but not Rho, Cdc42 and Rac) [43]. In the absence of
Gα16, HA-Ras was found to bind to TPR1 preferentially in
the activated conformation, however in the presence of
Gα16 binding was similar for activated and inactive HA-
Ras. Binding of Gα16 facilitated binding of HA-Ras to
TPR1 and led to accumulation of the activated Ras (Fig.
2A), apparently by stabilizing the activated conformation,
rather than by promoting GDP-GTP exchange. In contrast,
binding of HA-Ras had no effect on the binding of Gα16.
The physiological role of the formation of the Gα16-TPR1-
Ras complex remains to be explored.
Mammalian AGS3 and LGN proteins and their Drosophila
homologue Pins, which contain N-terminal TPR domains
and C-terminal domains with GoLoco motifs, act as scaf-
folds for Gαi and microtubule binding protein NuMA
[44,45]. This signaling complex plays a role in regulation
of cell polarity and has been considered in detail else-
where [7,10,11].
Another TPR protein, protein Ser/Thr phosphatase PP5, is
able to interact with Gα12 and Gα13 [46]. It remains to be
seen whether the ternary complexes exist that include PP5,
Gα12/13 and other proteins, or binding of Gα12/13 and
other proteins to the TPR domain of PP5 is mutually
exclusive, i.e. whether PP5 can be considered as a bona fide
scaffolding protein.
WD40 repeat proteins
Gβ belongs to the family of WD40 repeat proteins [47].
Gβγ acts as a scaffold itself by facilitating interaction
between activated GPCRs and Gα, and also by recruiting
GRK2 (β-ARK) to those GPCR that are phosphorylated by
this kinase [48]. It also initiates signal transduction by
recruiting other scaffolding or adaptor proteins. In yeast,
as discussed below, it recruits a scaffolding protein Ste5p
from the cytosol to the cell membrane, where it assembles
a signaling complex containing the components of the
MAPK cascade.
In mammalian cells, Gβ has been found to interact with
other WD40 repeat proteins, namely RACK1 (Receptor for
Activated C Kinase 1), dynein intermediate chain and an
uncharacterized protein AAH20044 [49-51]. Of these
three proteins, only Gβγ-RACK1 interaction has been
characterized in detail to date. RACK1 shares 57% amino
acid similarity with Gβ1 Unlike Gβ, RACK1 does not have
an N-terminal extension for binding Gγ. Although RACK1
does bind Gβγ, it does not interact with the Gα βγ heter-
otrimer (except that of transducin) or with Gα.
Binding of RACK1 to Gβγ affects some but not all Gβγ-
mediated functions: while activation of phospholipase C
β2 and adenylyl cyclase II are inhibited, Gβγ-mediated
chemotaxis and activation of MAP kinase cascade are not
affected. RACK1 does not affect signal transduction
through the Gα subunits of Gi, Gs or Gq.
The association with Gβγ induces translocation of RACK1
from the cytosol to the plasma membrane. This has been
suggested to be a mechanism to recruit PKC and other
RACK1-binding proteins to the membrane [49,50]. In
particular, Gβγ-RACK1 mediated PKC recruitment to
GPCRs could promote their efficient deactivation by this
kinase, in a manner similar to the recruitment of GRK2 by
Gβγ (see above). In addition, a number of Gβγ effectors,
Signaling complexes assembled by TPR-repeat scaffolding proteins: TPR1 (A) and RACK1 (B) Figure 2
Signaling complexes assembled by TPR-repeat scaffolding proteins: TPR1 (A) and RACK1 (B). See main text for description.
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such as Ca2+ channels, phospholipase C β2 and adenylyl
cyclase, as well as several Gα and RGS proteins can be reg-
ulated by PKC. Whether regulation of these proteins is
subject to fine tuning by the Gβγ-RACK1 interaction has
yet to be explored experimentally.
Another possibility is that the Gβγ-RACK1 complex might
build larger signaling complexes, employing scaffolding
properties of both Gβγ and RACK1. In this respect, it is of
particular interest that some proteins bind to/are regu-
lated by both Gβγ and RACK1. These include dynamin-1,
involved in GPCR internalization; Src, a tyrosine kinase
involved in Gβγ-mediated MAPK activation, and β-
integrin ([52] and references therein).
Importantly, RACK1 is able to homodimerize [53], a
property that may further expand its ability to form sign-
aling complexes as schematically depicted in Fig. 2B. A
model suggested by the latter study implicates a RACK1-
based signaling complex in regulation of NMDA receptor
(which is an ion channel) by a GPCR PAC1. According to
the model of [53], in the inactive state one molecule of
RACK1 in the dimer would bind NMDA receptor and link
it to PAC1 via Gα βγ trimer, while the other PACK1 mole-
cule would bind to a kinase Fyn, keeping it in a proximity
to NMDA receptor but nevertheless preventing it from
phosphorylating NMDAR (Fig. 2B). Upon PAC1 activa-
tion, the signaling complex is postulated to dissociate and
released Fyn to phosphorylate and thus activate NMDA
receptor [53]. It should be noted however that this model
requires the ability of RACK1 to associate with G protein
heterotrimer, which in most cases is not supported by
experimental evidence (see above).
Kelch repeat proteins, although unrelated in their primary
structure to WD40 repeats, form similar β-propeller struc-
tures that also mediate protein-protein interactions [54].
Two "Gβ-mimic" proteins, Gpb1 and Gpb2, containing
kelch repeats rather than WD40 repeats, have been found
to interact with a Gα subunit Gpa2 in yeast [55,56]. Nota-
bly, there are no known canonical Gβγ interacting with
Gpa2. Unlike canonical Gβγ, Gpb1 and Gpb2 do not facil-
itate, but on the contrary inhibit coupling of Gpa2 with its
cognate GPCR. Whether interaction of Gα with Kelch
repeat proteins is unique for yeast or similar interactions
may exist in mammals remains to be explored.
Other scaffolding proteins
Radixin is a member of the ezrin-radixin-moesin (ERM)
protein family that anchor actin filaments to the cell cor-
tex and membrane proteins, and function in Rho signal-
ing. ERM proteins are involved in such cytoskeleton-
dependent processes as cell morphogenesis, migration
and growth (reviewed [57,58]). Not surprisingly, ERM
proteins may be involved in tumor metastasis [59,60].
ERM proteins are negatively regulated by an intramolecu-
lar interaction between the N- and C-terminal domains,
and their ability to bind actin and other proteins is stimu-
lated when this interaction is disrupted and the binding
sites on radixin are unmasked [57].
Radixin was found to interact with activated (but not
GDP-bound) Gα13 via its N-terminal domain [61]. This
interaction apparently disrupted the interaction between
the N- and C-terminal domains, leading to radixin "con-
formational activation" and increased binding to F-actin
[61]. Dominant-negative deletion mutants of radixin
could block transformation induced by mutationally acti-
vated Gα13, suggesting that radixin could act downstream
of Gα13 in this process [61]. A suggestion that radixin may
mediate cellular effects of Gα13 was further substantiated
by a more recent study from our laboratory, which found
that the C-terminal domain of radixin activates Rac1 and
CAMKII, leading to stimulation of SRE (serum response
element)-dependent gene transcription ([62]; Fig. 3).
EBP50  (ezrin-radixin-moesin-binding phosphoprotein
50, also termed NHERF1 for Na+-H+ exchanger regulatory
factor 1) is a PDZ domain-containing scaffolding protein
known to bind to a variety of proteins, including ERM
proteins, channels, receptors, cytoskeletal elements, and
cytoplasmic proteins (for a recent review, see [63]). EBP50
was found to interact with Gαq via its PDZ domains [64].
The interaction was more efficient with activated than
with inactive form of Gαq; accordingly, stimulation of the
thromboxane A2receptor (which is coupled to Gq)
enhanced the Gαq-EBP50 interaction. EBP50 was also
able to interact with Gαs, and stimulation of the β2-adren-
Signaling from the Gα13-radixin complex Figure 3
Signaling from the Gα13-radixin complex.
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ergic receptor (coupled to Gαs) was found to promote
EBP50 binding to Gαs. However, several other Gα tested
(Gαi/o/t/z, Gα12/13, and Gα16) did not interact with EBP50.
Sequestering of Gαq by EBP50 was found to interfere with
the Gα-receptor interaction and to inhibit Gαq-dependent
stimulation of PLCβ ([64]; Fig. 4). EBP50 is known to
bind directly and to mediate recycling of a number of
receptors [65,66]; it was also found to inhibit internaliza-
tion of the thromboxane A2β receptor induced by Gαq
[67]. One of the future challenges would be to establish
whether, in addition to blocking Gα interactions with
receptors and effectors, Gα-EBP50 interaction may func-
tionally link Gαq and/or Gαs to other interacting partners
of EBP50.
EBP50 has been found to directly interact with RACK1,
another scaffolding protein capable of binding Gβγ (see
above) [68]. This interaction was found to be involved in
PKC-dependent regulation of an epithelial chloride chan-
nel cystic fibrosis transmembrane regulator (CFTR) [68].
Whether the ability of EBP50 and RACK1 to interact with
each other is relevant to their ability to bind subunits of
heterotrimeric G proteins is not known.
Scaffolding subunit of the protein phosphatase 2A (A subunit,
PR65) was found to interact with Gα12 (but not related
Gα13), which stimulated the activity of the catalytic PP2A
subunit bound to the complex independently of the acti-
vation state of Gα12 [69,70]. Intriguingly, the same scaf-
folding protein PR65 was found to interact with protein
phosphatase 5 (PP5) [71], and PP5 was shown to interact
with and to be activated by Gα12 and Gα13 [46]. It would
be interesting to establish whether PR65 may play a role
in assembling the Gα12/13-PP5 complex as well.
Scaffolding proteins that link heterotrimeric G proteins with
MAP kinase cascades. The first such scaffolding protein,
Ste5, was discovered in yeast (reviewed by [72,73]). Ste5
is able to bind all three kinases (MAPKKK, MAPKK and
MAPK) of the mating pathway, which promotes their
mutual interactions and thereby facilitates signal trans-
mission. Ste5 also binds to Gβγ. The latter property allows
the recruitment of the Ste5/MAPK signaling complex to
the stimulus-sensing receptor/G protein module, ena-
bling signal transduction from GPCR via Gβγ to the MAPK
cascade (Fig. 5A). Analogs of Ste5 act as scaffolds for other
MAP kinase cascades in both yeast and mammalian cells
[74,75], and some of them are also able to interact with
subunits of heterotrimeric G proteins.
Mammalian KSR1 protein (which shares no sequence
similarity with Ste5) assembles the kinases of the ERK
pathway (Raf-1, MEK1/2, ERK1/2) (reviewed by [74,76]).
KSR1 plays a role in ERK activation during inflammatory
and stress responses and has been implicated in the onset
of arthritis [77]. KSR1-facilitated ERK activation was also
found to be essential for long-term memory formation
and synaptic plasticity [78].
KSR-1 association with MEK kinases is constitutive, while
binding to Raf and recruitment of ERK to the complex are
Ras activation-dependent. Another protein constitutively
bound to KSR1 and required for maximal stimulation the
ERK cascade is casein kinase 2 [79]. KSR1 is able to inter-
act with Gβγ  via  the  γ subunit and is recruited to the
plasma membrane upon LPA stimulation ([80]; Fig. 5B).
JNK-interacting leucine zipper protein (JLP) is a scaffold-
ing protein (recently reviewed in [72]) involved in linking
JNK with its substrate transcription factors (Myc and Max)
and its upstream kinases (MKK4 and MEKK3) [81]. JLP
interacts with kinesin light chain 1, which is required for
its interaction with JNK and affects localization of the
complex [82]. JLP has recently been found to interact spe-
cifically with Gα12 and Gα13, but not Gαs, Gαi or Gαq [83].
Although JLP binds both activated and inactive Gα13, the
interaction is more pronounced with the activated form.
Accordingly, JLP-Gα13 interaction is enhanced by lyso-
phosphatidic acid (LPA) stimulation, which is known to
activate Gα13. LPA-induced JNK activation in living cells is
potentiated by overexpression of JLP. Thus, JLP appears to
function in linking GPCR signaling to JNK activation by
assembling a protein complex that involves Gα12 or Gα13
and the components of JNK signaling module ([83]; Fig.
5C). We have recently found that JLP can also assemble a
complex containing Gα13 and apoptosis signal-regulating
kinase 1 (ASK1), which is known to stimulate JNK and/or
p38 in response to stress stimuli [84]. Although the func-
tionality of this complex in terms of activation of down-
stream MAP kinases remains to be tested, this suggests
The role of EBP50 (NERF) in downregulation of G protein  signaling Figure 4
The role of EBP50 (NERF) in downregulation of G protein 
signaling.
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that JLP may link Gα12/13 signaling with JNK through
more than one kinase cascade. A physiological role for the
Gα13-JLP-JNK signaling complex in retinoic acid-induced
differentiation has recently been suggested [85].
Two JLP-related alternative splicing products are known
(JIP4 and SPAG9), which differ from JLP in their N-ter-
mini and appear to have different selectivity towards JNK
vs. p38 [86,87]. Since Gα12/13-binding region in JLP is at
the C-terminus and the C-terminal parts are conserved in
all three isoforms, JIP4 and SPAG9 would also likely be
able to interact with Gα12/13. Experimental confirmation
of this interaction and its functional implications have
not yet been reported.
Conclusion and perspectives
A number of scaffolding proteins for heterotrimeric G
proteins have been identified in the recent years, and
undoubtedly many more are still to be found. The knowl-
edge of the composition of possible complexes formed by
these scaffolds is essential for identification of the precise
signaling pathways they may be involved in. This has been
already achieved to some extent for a number of signaling
complexes that involve heterotrimeric G proteins.
Another layer of complexity is added by the events that
determine when and at what levels these scaffolds are
expressed in the cell and what are the fine tuning mecha-
nisms that regulate their interactions with particular part-
ners. In this respect, recent studies have highlighted some
possible fine tuning mechanisms. First, the expression of
scaffolding proteins may be regulated by relevant physio-
logical stimuli, as evidenced by the work of Kashef et al.
[85], who found that retinoic acid may induce expression
of JLP, a scaffolding protein that assembles a complex
transducing the signal from this ligand. Another example
of regulation of a G protein-binding scaffold by a physio-
logical stimulus, in this case growth factor stimulation
[76], is Ras-dependent degradation of a protein IMP that
controls KSR1 localization [88]. Another level of fine tun-
ing may be achieved by posttranslational modifications of
the proteins involved, and some cases of such regulation
are beginning to emerge. It was suggested that binding of
Gβγ may Ste5 may induce conformational changes in the
latter, which make activation of MAP kinases bound to
Ste5 more efficient [89]. Regulation of several G protein-
binding scaffolding proteins by phosphorylation has been
reported, including Ste5 and KSR1 [76,89]. Sumoylation
of the proteins of RGS-Rz subfamily was found to switch
their function from stimulation of GTPase activity of Gα
subunits to that of a scaffolding protein [90]. Clearly,
detailed knowledge of not only composition of the com-
plexes assembled by G protein-interacting scaffolding
proteins, but although intricate regulation of the proper-
ties of all components of these complexes will be neces-
sary for full understanding of their biological functions.
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